OMOP Concept 19102772

aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension [Gaviscon]

StandardDrugRxNorm404472Branded Drug
Maps from
7
Descendants
0
Valid from
1 Jan 1970
Valid to
31 Dec 2099
OMOP concepts

Concept Lookup Tool

Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.

Source codes that map to this concept

7 source codes normalize to aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension [Gaviscon] via the OMOP "Maps to" relationship.

Synonyms

Alternative names recorded for aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension [Gaviscon] across source vocabularies.

  • Gaviscon Extra Strength Liquid (aluminum hydroxide 254 MG / magnesium carbonate 237.5 MG) per 5 ML Oral Suspension

Where it sits in the hierarchy

Ordered by distance - 1 is a direct parent or child.

Broader concepts

(28)

Roll up to these when you need a wider cohort.

Get this concept via the API

Resolve aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension [Gaviscon] - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.

curl "https://api.omophub.com/v1/concepts/19102772?include_relationships=true" \
  -H "Authorization: Bearer $OMOPHUB_API_KEY"
Get your free API key3,000 calls/month free · no credit card